The grant, which builds on a five-year, $25 million partnership launched in 2016, will fund efforts to enhance care and support programs for Alzheimer's patients, provide educational materials to Edward Jones clients and associates, and advance critical research. The total commitment of $50 million over ten years is the largest ever pledged by a corporate partner to the Alzheimer's Association.
The Edward Jones Alzheimer's Research Fund currently supports Dominantly Inherited Alzheimer Network studies at Washington University in St. Louis focused on supporting effective and safe clinical trials that improve scientific understanding of inherited Alzheimer's disease. To support early detection, Edward Jones provides the Alzheimer's Association's 10 Warning Signs of Alzheimer's online education program to its financial advisors, who in turn host joint seminars with the organization aimed at providing clients and caregivers with information they can use to protect their health and wealth when facing a long-term illness.
According to a recent survey conducted by Edward Jones and Age Wave, U.S. retirees rank Alzheimer's and dementia as the most feared health condition in later life. More than five million Americans are living with Alzheimer's, while sixteen million serve as an unpaid caregiver to a loved one with Alzheimer's.
"As the number of people affected by Alzheimer's and other dementia continues to grow," said Alzheimer's Association president and CEO Harry Johns, "Edward Jones' extraordinary commitment to the cause is crucial in funding research, supporting education, advancing access to care, and broadening awareness of this disease."